New England Biolabs

NEBNext Ultra II Q5 Master Mix

#M0544S

38
Citing papers
331
Combined citations
Supplier page Find this product

Research areas

Genomics and Chromatin Dynamics8CRISPR and Genetic Engineering5Epigenetics and DNA Methylation4Cancer Genomics and Diagnostics3RNA modifications and cancer3RNA Research and Splicing3Genomics and Phylogenetic Studies2Chromosomal and Genetic Variations2

Papers citing this product

1
Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma
Cell Reports Medicine·2023·59 cit.·DOI
2
An embryonic stem cell-specific heterochromatin state promotes core histone exchange in the absence of DNA accessibility
Nature Communications·2020·53 cit.·DOI
3
Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing
Nature Communications·2022·52 cit.·DOI
4
The Integrator complex regulates microRNA abundance through RISC loading
Science Advances·2023·29 cit.·DOI
5
Eliminating accidental deviations to minimize generalization error and maximize replicability: applications in connectomics and genomics
bioRxiv (Cold Spring Harbor Laboratory)·2019·22 cit.·DOI
6
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid
Cell Reports Medicine·2023·18 cit.·DOI
7
Joint epigenome profiling reveals cell-type-specific gene regulatory programmes in human cortical organoids
Nature Cell Biology·2023·16 cit.·DOI
8
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia
Molecular Cancer·2023·14 cit.·DOI
9
Genetic variation is a key determinant of chromatin accessibility and drives differences in the regulatory landscape of C57BL/6J and 129S1/SvImJ mice
Nucleic Acids Research·2023·12 cit.·DOI
10
Design and deep learning of synthetic B-cell-specific promoters
Nucleic Acids Research·2023·9 cit.·DOI

Similar products

ProductVendorPricePapers
NEBNext Ultra II Q5 Master MixNew England Biolabs—67
NEBNext Ultra II Q5 Master MixNew England Biolabs—13